AMIRA Meditech

AMIRA Meditech is a Bulgarian startup that is focused on addressing the pressing issue of antimicrobial resistance (AMR) by developing a software solution to guide doctors during antibiotic prescription. The company's slogan succinctly captures its mission, emphasizing the crucial role of technology in combating AMR. AMIRA Meditech's software aims to provide guidance to medical specialists involved in antibiotic prescription, thereby ensuring optimal outcomes for patients while also contributing to the broader goal of averting the emergence of antimicrobial resistance. With its firm focus on the Health Care industry, AMIRA Meditech has positioned itself at the intersection of technology and healthcare, seeking to make a significant impact in a critical area. The startup recently secured a €50.00K Pre Seed Round investment on 21 May 2023, with Innovation Capital being the investor. This investment not only underscores the confidence of investors in AMIRA Meditech's vision but also provides the company with the necessary resources to further develop and scale its innovative solution. As a Bulgarian startup, AMIRA Meditech not only exemplifies the burgeoning potential within the country's entrepreneurial landscape but also holds the promise of contributing to global efforts in combating AMR. With a clear focus, a strong value proposition, and backing from investors such as Innovation Capital, AMIRA Meditech is poised to make strides in the fight against antimicrobial resistance and create impactful change within the healthcare industry.